What information on quality specifications should be communicated to clinicians, and how?

This publication has 22 references indexed in Scilit:

• Test result variation and the quality of evidence-based clinical guidelines
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 2004
• Importance of the choice of assumptions and models in the estimation of analytical quality specifications
  Accreditation and Quality Assurance, 2002
• Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus
  Scandinavian Journal of Clinical and Laboratory Investigation, 2001
• Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus
  Scandinavian Journal of Clinical and Laboratory Investigation, 2001
• Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
  European Heart Journal, 2000
• Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study
  Journal of Clinical Endocrinology & Metabolism, 1999
• Current databases on biological variation: pros, cons and progress
  Scandinavian Journal of Clinical and Laboratory Investigation, 1999
• Analytic bias specifications based on the analysis of effects on performance of medical guidelines
  Scandinavian Journal of Clinical and Laboratory Investigation, 1999
• Do We Know What Inappropriate Laboratory Utilization Is?
  JAMA, 1998
• Inappropriate use of laboratory services: long term combined approach to modify request patterns.
  BMJ, 1990